 profit slide india dr reddy profit indian drugmaker dr reddys fell 93 research cost rose sale flagged firm said profit 40m rupee 915000 â¼486000 three month december sale fell 8 47bn rupee dr reddys built reputation producing generic version bigname pharmaceutical product competition intensified firm company short new product launch recent annoucement december 2000 exclusive marketing right generic version famous antidepressant prozac maker eli lilly also lost key court case march 2004 banning selling version pfizers popular hypertension drug norvasc u research development new drug continuing apace rd spending rising 37 705m rupee key cause decrease profit alongside fall sale patent number wellknown product due run near future representing opportunity dr reddy whose share listed new york indian generic manufacturer sale dr reddys generic business fell 86 966m rupee another staple firm business sale ingredient drug also performed poorly sale 25 previous year 14bn rupee face strong competition home u europe dr reddys indian competitor gathering strength although face heavy competitive pressure